NYSEMKT: NRXSNeuraxis Inc Stock Ownership - Who owns Neuraxis?
Insider buying vs selling
Have Neuraxis Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Timothy Robert Henrichs | Chief Financial Officer | 2026-04-01 | 7,593 | $1.96 | $14.88kBuy |
| Thomas Joeseph Carrico | CRO CCO CPO | 2026-04-01 | 667 | $1.96 | $1.31kBuy |
| Brian Allen Carrico | Chief Executive Officer | 2026-04-01 | 8,060 | $1.96 | $15.80kBuy |
| Brian Hannasch | 10% Owner | 2026-02-12 | 40,000 | $4.92 | $196.80kBuy |
| Brian Hannasch | 10% Owner | 2026-02-11 | 40,000 | $4.65 | $186.00kBuy |
| Bradley Mitchell Watkins | Director | 2026-01-22 | 21,598 | $4.63 | $100.00kBuy |
| Gil Aharon | Director | 2026-01-22 | 21,598 | $4.63 | $100.00kBuy |
| Kristin A. Ferge | Director | 2026-01-22 | 21,598 | $4.63 | $100.00kBuy |
| Jane Elizabeth Keyser | Director | 2026-01-22 | 21,598 | $4.63 | $100.00kBuy |
| Gil Aharon | Director | 2025-12-23 | 286,138 | $3.52 | $1.01MBuy |
NRXS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NRXS insiders and whales buy or sell their stock.
NRXS Shareholders
What type of owners hold Neuraxis Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brian Hannasch | 10.83% | 1,211,522 | $9.79M | Insider |
| Christopher Robin Brown | 7.09% | 792,837 | $6.41M | Insider |
| Gil Aharon | 4.84% | 541,957 | $4.38M | Insider |
| Gary Merril Peterson | 4.63% | 518,120 | $4.19M | Insider |
| Aigh Capital Management LLC | 3.58% | 400,000 | $3.23M | Institution |
| Brian Allen Carrico | 3.11% | 348,178 | $2.81M | Insider |
| Thomas Joeseph Carrico | 2.97% | 331,903 | $2.68M | Insider |
| Rosalind Advisors Inc | 2.56% | 286,138 | $2.31M | Institution |
| Money Concepts Capital Corp | 1.99% | 222,605 | $1.80M | Institution |
| Panoramic Capital LLC | 1.47% | 165,000 | $1.33M | Institution |
NRXS vs Biotech Stocks
Neuraxis Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.